Novo Nordisk Looks to Target Hair Loss in Consumer Push
The maker of Ozempic and Wegovy seeks to expand its direct-to-consumer pharmaceutical business as rival Eli Lilly outpaces in weight-loss drugs.
Beauty
Analysis and advice on the fast-evolving beauty business.
What’s Driving Saudi Arabia’s Beauty Transformation
The country has emerged as the GCC region’s largest cosmetics market as societal change spurs sales and homegrown brands.
Opinion: China’s Beauty Giant Proya Has Its US Strategy Backwards
China’s biggest beauty company is getting ahead of itself by announcing distribution at Ulta Beauty without first building meaningful name recognition among American shoppers, writes Bloomberg’s Juliana Liu.
How AI’s Nouveau Riche Are Spending on Beauty
Silicon Valley is minting new multi-millionaires — and billionaires — at a rapid rate, as tech firms like SpaceX, OpenAI and Anthropic target huge IPOs. Fashion, travel and wellness are benefitting, but not all beauty companies can capitalise on the boom.
Baldness Drugs Are Wall Street’s Next Goldmine
Drugmakers working on the next generation of male hair loss treatments are seeing soaring share prices, reminiscent of a similar pattern with GLP-1 innovations.
One Nation Under Blonde
From blonde ‘bombshells’ to ‘blue-haired liberals’, hair has become a soft indicator of political affiliation. But these stereotypes are eroding, even as polarisation deepens.
At a $10.1 Billion Valuation, Whoop Turns to Women
The US wearables company is hoping to add more female customers with the launch of a new, more elevated design.
US-Canada Cosmetic Tariffs Threaten the $10 Beauty Impulse Buy
L’Oréal and Estée Lauder Companies are among the major beauty companies exposed to the new 50 percent tariffs through their manufacturing operations.
Can Underwear Be Skincare?
Labels like Underdays and Sylva are on the vanguard of a new category called 'carewear,' creating clothing with wellness or skincare benefits. But the business plan is still a work in progress.
Neutrogena Responds to Criticism Over How Brand Deal With Hayden Panettiere Ended
Following the actress’s untimely death, the skincare company acknowledged it had ‘made her feel unsupported during [a] difficult time.’
Beauty Is Growing. Not Everyone’s Benefitting.
Judging from the world’s largest beauty companies’ earnings reports, the industry’s growth is polarised, with gulfs forming between those gaining ground and those losing it.
A Luxury Skincare Line, Made for Younger Faces
La Prairie’s new Swiss Pristine collection, aimed at entry-level shoppers, is a big bet on how aspirational products can be.
China’s New Tourist Obsession Is a 24-Hour Spa
For less than the cost of many hotels, sprawling bathhouses offer soaking pools, sleeping lounges, lobster buffets and TikTok-ready wellness.
THE NEWS IN BRIEF
PR Agency CGC Launches Performance Media Division
Known for its premium beauty clients including Glossier and Hermès Beauty, the agency’s new division combines influencer marketing and AI insights.
Luxury Perfume Line Roja London Acquired by Extravaganza Beauty
Master perfumer and founder Roja Dove will remain with the brand in a new consultancy role.
Olaplex Names New CEO
Christoph Kaul will succeed Amanda Baldwin, who led the hair care label through its acquisition by Henkel earlier this year.
Perelel Expands C-Suite, Tapping Rare Beauty’s CMO
Known for its prenatal vitamins, the wellness label has hired Rare Beauty's Ashley Murphy as its chief marketing officer, while Anjelika Temple moves into the chief creative officer role.
Supergoop Announces Chief Commercial Officer
The sunscreen label has appointed former Coty executive Jamie Parker to the newly created role as it gears up to become a “global skin health company.”
L’Oréal Steals French Stock Market Crown From LVMH
The cosmetics group became France’s most valuable listed company on Tuesday, the first time since 2017 that a non-luxury company has claimed the top spot at the end of a trading day.
Kimberly-Clark Prepares Asset Sales to Win EU Nod for Kenvue Deal
The US consumer goods giant is preparing concessions to address EU antitrust concerns about its bid for Tylenol maker Kenvue that could help it win approval for the $40 billion deal, sources told Reuters.